Literature DB >> 25300997

Upregulated expression of human alpha-defensins 1, 2 and 3 in hypercholesteremia and its relationship with serum lipid levels.

Yun-Xi Li1, Chao-Qun Lin2, Da-Yu Shi3, Shu-Ying Zeng4, Wen-Sheng Li5.   

Abstract

Human alpha-defensins are natural antimicrobial peptides of neutrophils evolved in host defense reactions and circulating nonstressed alpha-defensins may be associated with serum lipid levels. The aim of this work was to examine whether the expression of alpha-defensins 1, 2 and 3 genes are changed and whether this changes are reversed following treatment in patients with hypercholesteremia. A total of 40 individuals of hypercholesteremia group were studied, compared with 40 individuals of normal control group. Protein levels and gene expression levels of alpha-defensins 1, 2 and 3 were significantly higher in patients with hypercholesteremia compared with subjects in normal control group. In patients with hypercholesteremia, protein levels of alpha-defensins 1, 2 and 3 correlated positively with the levels of total cholesterol and low-density lipoprotein cholesterol. Protein levels and gene expression levels of alpha-defensins 1, 2 and 3 were decreased significantly after a treatment with atorvastatin calcium 20mg daily compared with the patients before the treatment. Our results suggest that the expression of alpha-defensins 1, 2 and 3 genes is involved in dyslipidemia in patients with hypercholesteremia.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Defensin; Gene expression; Human neutrophil peptide; Hypercholesteremia

Mesh:

Substances:

Year:  2014        PMID: 25300997     DOI: 10.1016/j.humimm.2014.09.014

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  6 in total

1.  PPBP gene as a biomarker for coronary heart disease risk in postmenopausal Thai women.

Authors:  Chayasin Mansanguan; Yaowapa Maneerat
Journal:  PeerJ       Date:  2022-06-17       Impact factor: 3.061

2.  Distinct peripheral blood monocyte and neutrophil transcriptional programs following intracerebral hemorrhage and different etiologies of ischemic stroke.

Authors:  Paulina Carmona-Mora; Bradley P Ander; Glen C Jickling; Cheryl Dykstra-Aiello; Xinhua Zhan; Eva Ferino; Farah Hamade; Hajar Amini; Heather Hull; Frank R Sharp; Boryana Stamova
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-22       Impact factor: 6.200

3.  Upregulated expression of human cathelicidin LL-37 in hypercholesterolemia and its relationship with serum lipid levels.

Authors:  Yun-Xi Li; Bao-Zhen Li; Da-Zun Yan
Journal:  Mol Cell Biochem       Date:  2018-04-11       Impact factor: 3.396

4.  Increased alpha-defensin expression is associated with risk of coronary heart disease: a feasible predictive inflammatory biomarker of coronary heart disease in hyperlipidemia patients.

Authors:  Yaowapa Maneerat; Kriengchai Prasongsukarn; Surachet Benjathummarak; Wilanee Dechkhajorn; Urai Chaisri
Journal:  Lipids Health Dis       Date:  2016-07-18       Impact factor: 3.876

5.  PPBP and DEFA1/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease.

Authors:  Yaowapa Maneerat; Kriengchai Prasongsukarn; Surachet Benjathummarak; Wilanee Dechkhajorn
Journal:  Lipids Health Dis       Date:  2017-04-19       Impact factor: 3.876

6.  PR3 levels are impaired in plasma and PBMCs from Arabs with cardiovascular diseases.

Authors:  Abdelkrim Khadir; Dhanya Madhu; Sina Kavalakatt; Preethi Cherian; Monira Alarouj; Abdullah Bennakhi; Jehad Abubaker; Ali Tiss; Naser Elkum
Journal:  PLoS One       Date:  2020-01-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.